Skip to main content
Livermore
Livermore
ZHEN

Bionano Genomics, Inc.

BNGO
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
SEC CIK
0001411690

In the last 90 days, Bionano Genomics, Inc. insiders filed 2 open-market purchases and 0 sales; 34 institutions reported holding it in 13F filings for Q2 2026, worth $801.6K in total; no superinvestor holds it.

Holders of 5% or more of BNGO

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Bionano Genomics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of BNGO
HolderLatest formStakeChangeFirst filedLatest filingFiling
Ayrton Capital LLC13G9.99%528.2K sharesNewNov 13, 20251 filingNov 13, 2025SEC
CVI Investments, Inc.13G/A9.90%1.31M shares0.00 ppfrom 9.90%Jan 13, 20255 filingsAug 14, 2026SEC
Lind Global Fund III LP13G/A9.35%1.05M shares−0.55 ppfrom 9.90%Sep 24, 20253 filingsFeb 17, 2026SEC
Lincoln Alternative Strategies LLC13G5.42%525.0K sharesNewSep 17, 20251 filingSep 17, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

22 Schedule 13D and 13G filings on Bionano Genomics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on BNGO
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 14, 20262:42 PM ETCVI Investments, Inc.and 1 other13G/A9.90%1.31M shares0.00 ppfrom 9.90%Jun 30, 2026SEC
Feb 17, 20264:06 PM ETLind Global Fund III LPand 2 others13G/A9.35%1.05M shares−0.55 ppfrom 9.90%Dec 31, 2025SEC
Feb 17, 20262:46 PM ETCVI Investments, Inc.and 1 other13G/A9.90%1.13M shares0.00 ppfrom 9.90%Dec 31, 2025SEC
Nov 14, 20254:09 PM ETLind Global Fund III LPand 2 others13G/A9.90%514.3K shares0.00 ppfrom 9.90%Sep 30, 2025SEC
Nov 14, 20253:10 PM ETIroquois Capital Management, LLCand 2 others13G/A4.99%98.9K shares–Below 5%Sep 30, 2025SEC
Nov 14, 20252:44 PM ETIroquois Capital Management, LLCand 2 others13G/A4.99%509.7K shares−0.41 ppfrom 5.40%Below 5%Sep 30, 2025SEC
Nov 13, 20253:32 PM ETAyrton Capital LLCand 2 others13G9.99%528.2K sharesNewSep 30, 2025SEC
Sep 24, 20258:00 PM ETLind Global Fund III LPand 2 others13G9.90%1.01M sharesNewSep 17, 2025SEC
Sep 22, 202510:00 AM ETCVI Investments, Inc.and 1 other13G9.90%1.02M shares+5.00 ppfrom 4.90%Sep 16, 2025SEC
Sep 19, 20254:34 PM ETIntracoastal Capital, LLCand 2 others13G4.99%508.4K sharesNewBelow 5%Sep 16, 2025SEC
Sep 18, 20258:13 AM ETIroquois Capital Management, LLCand 2 others13G5.40%525.0K sharesNewSep 16, 2025SEC
Sep 17, 20254:05 PM ETLincoln Alternative Strategies LLC13G5.42%525.0K sharesNewSep 17, 2025SEC
May 12, 202512:08 PM ETCVI Investments, Inc.and 1 other13G/A4.90%157.9K shares−2.80 ppfrom 7.70%Below 5%Mar 31, 2025SEC
Jan 13, 20259:52 AM ETCVI Investments, Inc.and 1 other13G7.70%10.7M sharesNewJan 3, 2025SEC
Feb 13, 2024Vanguard Group Inc13G/AOld format–––SEC
Jul 7, 20234:35 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 9, 2023Vanguard Group Inc13G/AOld format–––SEC
Jan 30, 20234:03 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 9, 2022Vanguard Group Inc13GOld format–New–SEC
Feb 4, 20224:12 PM ETBlackRock Inc.13GOld format–New–SEC
Feb 9, 2021Hudson Bay Capital Management LP13G/AOld format–––SEC
Jan 21, 2021Domain Partners VIII, L.P.13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Bionano Genomics, Inc. shares.

No Form 144 notices for Bionano Genomics, Inc. are on file.